Baillie Gifford & Co. Has $34.26 Million Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Baillie Gifford & Co. cut its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 9.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,589,851 shares of the health services provider's stock after selling 170,057 shares during the period. Baillie Gifford & Co. owned approximately 0.96% of Teladoc Health worth $34,261,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in TDOC. Forum Financial Management LP boosted its stake in shares of Teladoc Health by 14.4% during the first quarter. Forum Financial Management LP now owns 3,094 shares of the health services provider's stock valued at $223,000 after purchasing an additional 390 shares during the period. Canada Pension Plan Investment Board boosted its holdings in shares of Teladoc Health by 21.6% in the first quarter. Canada Pension Plan Investment Board now owns 2,900 shares of the health services provider's stock valued at $209,000 after purchasing an additional 515 shares during the period. Mariner LLC boosted its holdings in shares of Teladoc Health by 2.7% in the fourth quarter. Mariner LLC now owns 19,877 shares of the health services provider's stock valued at $470,000 after purchasing an additional 525 shares during the period. Nations Financial Group Inc. IA ADV grew its stake in Teladoc Health by 7.9% in the first quarter. Nations Financial Group Inc. IA ADV now owns 8,475 shares of the health services provider's stock worth $611,000 after purchasing an additional 622 shares in the last quarter. Finally, State of Wyoming increased its holdings in Teladoc Health by 16.0% during the 2nd quarter. State of Wyoming now owns 4,539 shares of the health services provider's stock worth $115,000 after purchasing an additional 626 shares during the period. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Buying and Selling

In other Teladoc Health news, insider Laizer Kornwasser sold 7,882 shares of the business's stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total transaction of $151,176.76. Following the completion of the transaction, the insider now owns 57,223 shares in the company, valued at approximately $1,097,537.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Andrew Turitz sold 6,190 shares of the business's stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the sale, the executive vice president now owns 39,429 shares in the company, valued at $572,509.08. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Laizer Kornwasser sold 7,882 shares of the stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total transaction of $151,176.76. Following the completion of the transaction, the insider now owns 57,223 shares in the company, valued at $1,097,537.14. The disclosure for this sale can be found here. Insiders sold 134,441 shares of company stock valued at $2,025,041 in the last three months. 1.63% of the stock is owned by corporate insiders.

Teladoc Health Trading Up 0.6 %

Shares of NYSE TDOC traded up $0.09 during trading on Thursday, reaching $14.59. The stock had a trading volume of 3,405,724 shares, compared to its average volume of 4,687,608. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. The company has a market cap of $2.44 billion, a P/E ratio of -10.89 and a beta of 0.94. Teladoc Health, Inc. has a fifty-two week low of $13.59 and a fifty-two week high of $30.41. The business's 50-day moving average price is $16.38 and its 200-day moving average price is $18.14.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.05. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The company had revenue of $660.50 million during the quarter, compared to the consensus estimate of $670.79 million. During the same period in the previous year, the company posted ($0.23) EPS. Teladoc Health's revenue was up 3.6% compared to the same quarter last year. On average, equities research analysts predict that Teladoc Health, Inc. will post -1.07 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on TDOC. Truist Financial lowered their target price on Teladoc Health from $23.00 to $17.00 and set a "hold" rating for the company in a report on Wednesday, March 6th. Piper Sandler dropped their target price on shares of Teladoc Health from $30.00 to $25.00 and set an "overweight" rating on the stock in a report on Wednesday, February 21st. DA Davidson dropped their price objective on shares of Teladoc Health from $22.00 to $18.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 21st. Canaccord Genuity Group cut their price target on Teladoc Health from $34.00 to $28.00 and set a "buy" rating on the stock in a report on Wednesday, February 21st. Finally, Barclays cut their price objective on shares of Teladoc Health from $26.00 to $25.00 and set an "overweight" rating on the stock in a research report on Wednesday, February 21st. Nine analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and an average target price of $22.43.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.